Botswana Ministry of Health
12
0
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
8.3%
1 terminated/withdrawn out of 12 trials
90.9%
+4.4% vs industry average
50%
6 trials in Phase 3/4
20%
2 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
POC HIV Testing and Early DTG Use for Infants
Role: collaborator
Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2
Role: collaborator
Botswana Combination Prevention Project
Role: collaborator
Open Label Extension (OLE) of the TDF2 Study, Botswana
Role: collaborator
Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care
Role: collaborator
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Role: collaborator
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons
Role: collaborator
Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana
Role: collaborator
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
Role: collaborator
The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
Role: collaborator
Botswana Diarrheal Diseases Study
Role: collaborator
Botswana Tenofovir Oral HIV Prophylaxis Trial
Role: collaborator
All 12 trials loaded